Hypotensive Anesthesia for Orthognathic Surgery

Status Not yet recruiting

Clinical Trial Summary

The overall objective of this double blinded, randomized controlled trial (RCT) is to compare specific outcomes of three medications (Dexmedetomidine, Nicardipine, and Labetalol) which are routinely used to lower blood pressure used during general anesthesia for orthognathic (jaw) surgery. The outcome measures for the study will be surgical field visibility, estimated blood loss, hemodynamic parameters, operation time, and adverse events. The specific objectives of this study are to compare: 1. Dexmedetomidine, Nicardipine, and Labetalol's effect on the quality of the surgical field. (Primary Outcome) 2. Dexmedetomidine, Nicardipine, and Labetalol's effect on estimated blood loss. 3. Dexmedetomidine, Nicardipine, and Labetalol's effect on hemodynamic parameters including systolic blood pressure, mean arterial pressure, and heart rate. 4. Dexmedetomidine, Nicardipine, and Labetalol's effect on operation time. 5. Dexmedetomidine, Nicardipine, and Labetalol's effect on adverse events. The investigators will evaluate healthy adult male and female patients who require jaw surgery at Boston Medical Center. The anticipated 90 participants will be randomized into three groups: ) A Labetalol group in which the patients receive hypotensive anesthesia with the aid of labetalol, 2) A Nicardipine group in which the patients receive hypotensive anesthesia with the aid of nicardipine, and 3) A Dexmedetomidine group in which the patients receive hypotensive anesthesia with the aid of dexmedetomidine. The time it will take for each individual participant ranges from 1-3 months. This time includes the pre-operative visit, the surgical procedure, a 1-week post-operation visit, and then followed for 30 days post-operatively after which the patient's participation in the study will conclude.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06093893
Study type	Interventional
Source	Boston Medical Center
Contact	Pushkar Mehra, DMD
Phone	617-638-4350
Email	pushkar.mehra@bmc.org
Status	Not yet recruiting
Phase	Phase 4
Start date	May 2024
Completion date	March 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05536596` - Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy	Phase 2/Phase 3
Withdrawn	`NCT03318757` - Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery	Phase 4
Not yet recruiting	`NCT03486951` - Outpatient Orthognathic Surgery: "AMBOST" a One Year Study
Recruiting	`NCT05009056` - Functional Appliance for Orthognathic Surgery	N/A
Recruiting	`NCT01989715` - Body Posture Assessment Considering Jaws Position Before and After Orthognathic Surgery on Adult Patient.	N/A
Completed	`NCT01461031` - Effect of Nefopam on Acute Postoperative Pain in Patients Undergoing Orthognathic Surgery	N/A
Completed	`NCT03986723` - 3D Printed Models in 3D Virtual Treatment Planning of Orthognathic Surgery
Completed	`NCT05316545` - Retrospective Analysis of Anesthesia Procedure in Orthognathic Surgery
Completed	`NCT06233188` - Effect of Customized Lateral Nasal Wall Osteotomy on the Pterygomaxillary Separation During le Fort I Down-fracture	N/A
Completed	`NCT03843138` - Feasibility and Performance of a Novel 3D Virtual Treatment Planning Software: an International, Multi-centric, Prospective Study
Not yet recruiting	`NCT06338982` - Fracture Pattern Following Bilateral Sagittal Split Osteotomy With or Without Impacted Third Molars	N/A
Completed	`NCT06188403` - Comparison Between Prebent Plates and Custom Plates After le Fort 1 in Orthognathic Surgery	N/A
Completed	`NCT06301204` - Effectiveness Of Tranexamic Acıd Application Wıth Different Doses On Bleeding, Edema And Physician Comfort In Orthognathıc Surgery Patients	N/A
Not yet recruiting	`NCT04353635` - Prediction Accuracy of Dolphin 3D in Bimax Surgery for Class III
Withdrawn	`NCT03433144` - The Effects of Tranexamic Acid on Blood Loss During Orthognathic Surgery	Phase 4
Completed	`NCT06103422` - Change in Taste Sensation After Orthognathic Surgery	N/A
Suspended	`NCT04910074` - LLLT Effects on Inferior Alveolar Nerve (IAN) Recovery Post-orthognathic Surgery	N/A
Recruiting	`NCT05717322` - TENS and Orthognathic Surgery	N/A
Completed	`NCT05184725` - CARINAE for Stress Relief in Perioperative Care	N/A
Active, not recruiting	`NCT05271383` - Study Evaluating the Performance and Safety of Global D Implants Indicated for Orthognathic Surgery

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.